Form 8-K Summary
Registrant and reporting date: The filing identifies the registrant as Sarcos Technology and Robotics Corporation, not Palladyne AI Corp. The report was filed September 1, 2023, concerning an event effective August 31, 2023. The company was an emerging growth company, with common stock traded under STRC and warrants under STRCW on Nasdaq.
Business Context and Reporting Period
This Form 8-K reports the execution of a Separation Agreement and Release with Jorgen Pedersen, who ceased serving as Chief Operating Officer of the company and its subsidiaries on July 12, 2023. The agreement became effective August 31, 2023.
Financial and Other Key Metrics
- Mr. Pedersen will receive aggregate severance payments of $170,767.20, less applicable withholdings, paid at $28,461.20 per month for six months following the July 12, 2023 separation date.
- The company will directly pay COBRA health coverage premiums, or provide equivalent taxable monthly payments, for up to six months, subject to stated eligibility conditions.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.
Material Changes and Contingencies
The previously anticipated advisory role for Mr. Pedersen will not continue. If a change in control occurred during the period from the separation date through October 12, 2023, the agreement provided for additional benefits, including a revised lump-sum severance payment, a $119,537.04 bonus severance payment, and accelerated vesting of outstanding unvested equity awards, subject to the agreement’s terms.
Guidance, Outlook, Risks, and Unusual Items
The filing contains no financial guidance or operating outlook. The principal unusual item is the executive separation arrangement and related severance obligations. Mr. Pedersen provided a general release of the company and its affiliates in exchange for the benefits.
Investor Verification Items
- Confirm the registrant identity, because the supplied metadata names Palladyne AI Corp., while the filing names Sarcos Technology and Robotics Corporation.
- Review Exhibit 10.1 for the complete separation agreement, including the change-in-control provisions and any omitted schedules or exhibits.
- Assess the accounting treatment and cash impact of the severance, benefits, and any potential equity-award acceleration.
- Verify whether a change in control occurred during the specified three-month period and whether additional benefits became payable.